| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 03/05/2014 | CN103619841A Heteroaryl compounds and methods of use thereof |
| 03/05/2014 | CN103619834A Derivatives of N-[(1H-pyrazol-1-yl)aryl]-1H-indole or 1H-indazole-3-carboxamide, their preparation and their use as P2Y12 antagonists |
| 03/05/2014 | CN103613596A Preparation method of triazolopyridine derivative containing trifluoromethyl |
| 03/05/2014 | CN103613595A Preparation method of amide urea type compound |
| 03/05/2014 | CN103613594A Preparation method of triazolopyridine containing trifluoromethyl |
| 03/05/2014 | CN103613593A Preparation method of amide urea derivative |
| 03/05/2014 | CN103613592A Synthesis method of aromatic ring or aromatic heterocyclic ring-fused amide |
| 03/05/2014 | CN103613591A Compounds adopted as cMet inhibitor, preparation method and uses thereof |
| 03/05/2014 | CN103613587A N,N-substituted 3-aminopyrrolidine compound capable of being used as monoamine reuptake inhibitor |
| 03/05/2014 | CN102498091B Glycine compound |
| 03/05/2014 | CN102432535B Method for extracting and separating huperzine A and huperzine B from huperzia serrata |
| 03/05/2014 | CN102083790B Spiro(5.5)undecane derivatives |
| 03/04/2014 | US8664397 Pyrrolopyridine-2-carboxylic acid amide derivative useful as inhibitor of glycogen phosphorylase |
| 03/04/2014 | US8664396 Photoluminescent metal complexes for protein staining |
| 03/04/2014 | US8664379 Fused heterocyclic compounds as ion channel modulators |
| 03/04/2014 | US8664240 R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and L-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial |
| 03/04/2014 | US8664230 Pyridopyrimidine derivatives and use thereof |
| 03/04/2014 | US8664207 Organic compounds |
| 03/04/2014 | US8663606 Method of producing a cationic liposomal preparation comprising a lipophilic compound |
| 02/27/2014 | WO2014031750A1 Acenaphthylene imide-derived semiconductors |
| 02/27/2014 | WO2014031595A1 Haptens of paliperidone |
| 02/27/2014 | WO2014031170A1 Pyrido[4,3-b]indole and pyrido[3,4-b]indole derivatives and methods of use |
| 02/27/2014 | WO2014031165A1 Compounds and methods of treating diabetes |
| 02/27/2014 | WO2014030743A1 Heterocycic compound |
| 02/27/2014 | WO2014030128A1 Diazepinone derivatives useful for the treatment of fragile x syndrome, parkinsons or reflux disease |
| 02/27/2014 | WO2014029723A1 New bicyclicpyridine derivatives |
| 02/27/2014 | WO2014029713A1 Method for producing linear and/or cyclic carbonate esters |
| 02/27/2014 | WO2014029684A1 Pesticidally active pyridyl- and pyrimidyl- substituted pyrazole derivatives |
| 02/27/2014 | WO2014029250A1 Benazepine compound and application thereof |
| 02/27/2014 | WO2014011900A3 Inhibitors of the fibroblast growth factor receptor |
| 02/27/2014 | WO2014002061A3 Substituted terrylene and quaterrylene derivates and use as semiconductors thereof |
| 02/27/2014 | WO2013164839A3 Amorphous form of apixaban, process of preparation and compositions thereof |
| 02/27/2014 | WO2013012915A8 Heterocyclic compounds and uses thereof |
| 02/27/2014 | US20140058107 Apixaban preparation process |
| 02/27/2014 | US20140058100 Tetrahydroisoquinolin-1-one derivative or salt thereof |
| 02/27/2014 | US20140058097 Pharmaceutical composition for treating alzheimer's disease |
| 02/27/2014 | US20140057938 KAT ll INHIBITORS |
| 02/27/2014 | US20140057937 Antagonists of chemokine receptors |
| 02/27/2014 | US20140057920 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity |
| 02/27/2014 | US20140057902 Diazepinone derivatives |
| 02/27/2014 | US20140057900 Pro-Neurogenic Compounds |
| 02/27/2014 | US20140057899 Quinolyl pyrrolo pyrimidyl condensed-ring compound and salt thereof |
| 02/27/2014 | US20140057896 Pyridone and aza-pyridone compounds and methods of use |
| 02/27/2014 | US20140057895 Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof |
| 02/27/2014 | US20140057894 Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators |
| 02/27/2014 | US20140057893 Substituted cycloproply compounds, compositions containing such compounds and methods of treatment |
| 02/27/2014 | US20140057891 Substituted 6,5-Fused Bicyclic Heteroaryl Compounds |
| 02/27/2014 | US20140056849 Substituted azaindole compounds, salts, pharmaceutical compositions thereof and methods of use |
| 02/26/2014 | EP2700679A1 Novel compound having alpha-cyanoacrylate structure, dye, and coloring photosensitive composition |
| 02/26/2014 | EP2700633A1 Method for producing linear and/or cyclic carbonate esters |
| 02/26/2014 | EP2700403A1 Therapeutic agent for tumor |
| 02/26/2014 | EP2699576A1 Pyrazolospiroketone derivatives for use as acetyl - coa carboxylase inhibitors |
| 02/26/2014 | EP2699575A1 Triazolopyridines |
| 02/26/2014 | EP2699574A1 Bicyclic heterocycle compounds and their uses in therapy |
| 02/26/2014 | EP2699573A2 7-(3,5-dimethyl-4-isoxazolyl)-8-(methyloxy)-1h-imidazo[4,5-c]quinoline derivatives |
| 02/26/2014 | EP2699572A1 Heterocyclic compounds as kinase inhibitors |
| 02/26/2014 | EP2699571A2 Materials for organic electroluminescent devices |
| 02/26/2014 | EP2699562A1 Bicyclic heterocycle compounds and their uses in therapy |
| 02/26/2014 | EP2699561A1 Androgen receptor modulating carboxamides |
| 02/26/2014 | CN103608350A Triazolopyridine compounds |
| 02/26/2014 | CN103608349A Solid forms and salts of tetrahydro-pyrido-pyrimidine derivatives |
| 02/26/2014 | CN103608348A Crystal of fused heterocyclic compound |
| 02/26/2014 | CN103608347A 咪唑并吡啶化合物 Imidazopyridine compound |
| 02/26/2014 | CN103608346A Naphthyridine derivatives as inhibitors of hypoxia inducible factor (HIF) hydroxylase |
| 02/26/2014 | CN103608335A Pyrimidine derivatives for the treatment of viral infections |
| 02/26/2014 | CN103601910A Preparation method of matrine molecule surface blotting polymer material |
| 02/26/2014 | CN103601725A Process for the manufacture of pharmaceutically active compounds |
| 02/26/2014 | CN103601674A Compounds for inhibiting dipeptide kininase, preparation method and applications thereof |
| 02/26/2014 | CN102471317B Aminopyridine derivatives for treating tumors and inflammatory diseases |
| 02/26/2014 | CN102382129B Spirocycles-substituted phosphodiesterase inhibitor |
| 02/26/2014 | CN102131810B Diketone fused azolopiperidines and azolopiperazines as anti-HIV agents |
| 02/26/2014 | CN101918407B Beta-lactamase inhibitors |
| 02/26/2014 | CN101659593B Organic electroluminescent compound and organic electroluminescent device using the same |
| 02/26/2014 | CN101203515B Pyrido[2,3-d]pyrimidines used as HCV inhibitors, and methods for the preparation thereof |
| 02/25/2014 | US8658699 Chemical permeation enhancers enhance nerve blockade by toxins |
| 02/25/2014 | US8658666 Substituted imidazoquinolines and imidazonaphthyridines |
| 02/25/2014 | US8658654 Receptor-type kinase modulators and methods of use |
| 02/25/2014 | US8658649 Kinase inhibitor |
| 02/25/2014 | US8658637 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof |
| 02/25/2014 | CA2777632C Imidazole derivatives as casein kinase inhibitors |
| 02/25/2014 | CA2659851C 2-methylmorpholine pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors |
| 02/25/2014 | CA2630410C 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents |
| 02/20/2014 | WO2014028600A2 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF |
| 02/20/2014 | WO2014028597A2 3-CYCLOHEXENYL AND CYCLOHEXYL SUBSTITUTED INDOLE AND INDAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF |
| 02/20/2014 | WO2014028591A2 N-ALKYLATED INDOLE AND INDAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF |
| 02/20/2014 | WO2014028589A2 4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF |
| 02/20/2014 | WO2014028479A1 Quinoxaline derivatives as gpr6 modulators |
| 02/20/2014 | WO2014028459A1 1,4-disubstituted pyridazine analogs and methods for treating smn-deficiency-related conditions |
| 02/20/2014 | WO2014028025A1 Compositions and methods for treating myotonic dystrophy type 1 |
| 02/20/2014 | WO2014027669A1 Pyrroloquinoline quinone tetraalkali salt, crystals thereof, method for manufacturing same, and composition |
| 02/20/2014 | WO2014027300A1 Bicyclic heteroaryl cycloalkyldiamine derivatives as inhibitors of spleen tyrosine kinases (syk) |
| 02/20/2014 | WO2014027112A1 Tris(hetero)arylpyrazoles and use thereof |
| 02/20/2014 | WO2014027078A1 Inhibitor compounds of phosphodiesterase type 10a |
| 02/20/2014 | WO2014026984A1 Azaindole carboxylic acid amides and azaindole thiocarboxylic acid amides for use as insecticides and acaricides |
| 02/20/2014 | WO2014026467A1 Bicyclic substituted pyrimidine compounds |
| 02/20/2014 | WO2014026330A1 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF |
| 02/20/2014 | WO2014026329A1 N-alkylated indole and indazole compounds as rorgammat inhibitors and uses thereof |
| 02/20/2014 | WO2014026328A1 3-cyclohexenyl substituted indole and indazole compounds as rorgammat inhibitors and uses thereof |
| 02/20/2014 | WO2014026327A1 4-heteroaryl substituted benzoic acid compounds as rorgammat inhibitors and uses thereof |
| 02/20/2014 | WO2014026244A1 Photoactive optoelectronic and transistor devices |